|
1
|
Arafat SN, Suelves AM, Spurr-Michaud S,
Chodosh J, Foster CS, Dohlman CH and Gipson IK: Neutrophil
collagenase, gelatinase, and myeloperoxidase in tears of patients
with Stevens-Johnson syndrome and ocular cicatricial pemphigoid.
Ophthalmology. 121:79–87. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Robert HR Jr (ed): Ophthalmic Pathology
and Intraocular Tumors. In: Basic and Clinical Science Course
(BCSC). American Academy of Ophthalmology, pp54-56, 2014.
|
|
3
|
External Disease and Cornea: In: Basic and
Clinical Science Course (BCSC). American Academy of Ophthalmology,
pp344-345, 2014.
|
|
4
|
Dacosta J: Ocular cicatricial pemphigoid
masquerading as chronic conjunctivitis: A case report. Clin
Ophthalmol. 6:2093–2095. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chan RY, Bhol K, Tesavibul N, Letko E,
Simmons RK, Foster CS and Ahmed AR: The role of antibody to human
beta4 integrin in conjunctival basement membrane separation:
Possible in vitro model for ocular cicatricial pemphigoid. Invest
Ophthalmol Vis Sci. 40:2283–2290. 1999.PubMed/NCBI
|
|
6
|
Tyagi S, Bhol K, Natarajan K,
Livir-Rallatos C, Foster CS and Ahmed AR: Ocular cicatricial
pemphigoid antigen: Partial sequence and biochemical
characterization. Proc Natl Acad Sci USA. 93:14714–14719.
1996.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Saw VPJ, Schmidt E, Offiah I, Galatowicz
G, Zillikens D, Dart JK, Calder VL and Daniels JT: Profibrotic
phenotype of conjunctival fibroblasts from mucous membrane
pemphigoid. Am J Pathol. 178:187–197. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Saw VPJ, Offiah I, Dart RJ, Galatowicz G,
Dart JK, Daniels JT and Calder VL: Conjunctival interleukin-13
expression in mucous membrane pemphigoid and functional effects of
interleukin-13 on conjunctival fibroblasts in vitro. Am J Pathol.
175:2406–2415. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chan MF, Sack R, Quigley DA, Sathe S,
Vijmasi T, Li S, Holsclaw D, Strauss EC and McNamara NA: Membrane
array analysis of tear proteins in ocular cicatricial pemphigoid.
Optom Vis Sci. 88:1005–1009. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Filip-Ciubotaru F, Manciuc C, Stoleriu G
and Foia L: NADPH Oxidase: Structure and activation mecanisms
(review). Note I. Rev Med Chir Soc Med Nat Iasi. 120:29–33.
2016.PubMed/NCBI
|
|
11
|
Căruntu C, Boda D, Musat S, Căruntu A and
Mandache E: Stress-induced mast cell activation in glabrous and
hairy skin. Mediators Inflamm. 2014(105950)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ahmed AR, Foster S, Zaltas M, Notani G,
Awdeh Z, Alper CA and Yunis EJ: Association of DQw7 (DQB1*0301)
with ocular cicatricial pemphigoid. Proc Natl Acad Sci USA.
88:11579–11582. 1991.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xu HH, Werth VP, Parisi E and Sollecito
TP: Mucous membrane pemphigoid. Dent Clin North Am. 57:611–630.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Labowsky MT, Stinnett SS, Liss J, Daluvoy
M, Hall RP III and Shieh C: Clinical implications of direct
immunofluorescence findings in patients with ocular mucous membrane
pemphigoid. Am J Ophthalmol. 183:48–55. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hingorani M and Lightman S: Ocular
cicatricial pemphigoid. Curr Opin Allergy Clin Immunol. 6:373–378.
2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ilie MA, Caruntu C, Lupu M, Lixandru D,
Tampa M, Georgescu SR, Bastian A, Constantin C, Neagu M, Zurac SA,
et al: Current and future applications of confocal laser scanning
microscopy imaging in skin oncology. Oncol Lett. 17:4102–4111.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ilie MA, Caruntu C, Lixandru D, Tampa M,
Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and
Boda D: In vivo confocal laser scanning microscopy imaging of skin
inflammation: Clinical applications and research directions. Exp
Ther Med. 17:1004–1011. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mondino BJ and Brown SI: Ocular
cicatricial pemphigoid. Ophthalmology. 88:95–100. 1981.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Elder MJ, Bernauer W, Leonard J and Dart
JK: Progression of disease in ocular cicatricial pemphigoid. Br J
Ophthalmol. 80:292–296. 1996.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Williams GP, Radford C, Nightingale P,
Dart JK and Rauz S: Evaluation of early and late presentation of
patients with ocular mucous membrane pemphigoid to two major
tertiary referral hospitals in the United Kingdom. Eye (Lond).
25:1207–1218. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Brănişteanu DE, Pintilie A, Andreş LE,
Dimitriu A, Oanţă A, Stoleriu G and Brănişteanu DC: Ethiopatogenic
hypotheses in lichen planus. Rev Med Chir Soc Med Nat Iasi.
120:760–767. 2016.PubMed/NCBI
|
|
22
|
Schaas BA, Ivan S, Titianu M, Condratovici
CP, Maier A and Schaas CM: Biochemical markers predicting the risk
of gestational diabetes mellitus. Mater Plast. 54:133–136.
2017.
|
|
23
|
Brănişteanu DE, Brănişteanu DC, Stoleriu
G, Ferariu D, Voicu CM, Stoica LE, Căruntu C, Boda D,
Filip-Ciubotaru FM, Dimitriu A, et al: Histopathological and
clinical traps in lichen sclerosus: A case report. Rom J Morphol
Embryol. 57 (Suppl 2):817–823. 2016.PubMed/NCBI
|
|
24
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical mometasone furoate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Branisteanu DE, Pintilie A, Dimitriu A,
Cerbu A, Ciobanu D, Oanta A and Tatu AL: Clinical, laboratory and
therapeutic profile of lichen planus. Rev Med Chir Soc Med Nat
Iasi. 125:25–32. 2017.
|
|
26
|
Brănişteanu DE, Cotrutz CE, Luca MC,
Molodoi DA, Stoica LE, Ianoşi SL, Cianga CM and Brănişteanu DC:
Morphopathological stigmata in acne fulminans. Rom J Morphol
Embryol. 56:1185–1190. 2015.PubMed/NCBI
|
|
27
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tatu AL, Elisei AM, Chioncel V, Miulescu M
and Nwabudike LC: Immunologic adverse reactions of β-blockers and
the skin (Review). Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Neff AG, Turner M and Mutasim DF:
Treatment strategies in mucous membrane pemphigoid. Ther Clin Risk
Manag. 4:617–626. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kempen JH, Daniel E, Gangaputra S, Dreger
K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer
KJ, et al: Methods for identifying long-term adverse effects of
treatment in patients with eye diseases: The Systemic
Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
Ophthalmic Epidemiol. 15:47–55. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Pujari SS, Kempen JH, Newcomb CW,
Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke
GA, Nussenblatt RB, et al: Cyclophosphamide for ocular inflammatory
diseases. Ophthalmology. 117:356–365. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Foster CS, Chang PY and Ahmed AR:
Combination of rituximab and intravenous immunoglobulin for
recalcitrant ocular cicatricial pemphigoid: A preliminary report.
Ophthalmology. 117:861–869. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ilie MA, Caruntu C, Tampa M, Georgescu SR,
Matei C, Negrei C, Ion RM, Constantin C, Neagu M and Boda D:
Capsaicin: Physicochemical properties, cutaneous reactions and
potential applications in painful and inflammatory conditions. Exp
Ther Med. 18:916–925. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ghiţă MA, Căruntu C, Rosca AE, Căruntu A,
Moraru L, Constantin C, Neagu M and Boda D: Real-time investigation
of skin blood flow changes induced by topical capsaicin. Acta
Dermatovenerol Croat. 25:223–227. 2017.PubMed/NCBI
|
|
35
|
Branisteanu D, Caruntu C, Negrei C, Ghita
MA, Caruntu A, Badarau AI, Buraga I, Boda D and Albu A: Capsaicin,
a hot topic in skin pharmacology and physiology. Farmacia.
63:487–491. 2015.
|
|
36
|
Lupu MN, Miulescu M, Ștefanopol IA,
Stoleriu G, Matei MN, Manolache N, Vasincu D, Ciobotaru OR and
Costuleanu M: Effect of 2,6-diisopropylphenol and
1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy) propane as anesthetic. Rev
Chim (Bucharest). 70:1888–1892. 2019.
|
|
37
|
Ciobotaru OR, Lupu MN, Rebegea LF,
Ciobotaru OC, Duca OM, Tatu AL, Voinescu CD, Stoleriu G, Earar K
and Miulescu M: Dexamethasone-chemical structure and mechanisms of
action in prophylaxis of postoperative side effects. Rev Chim
(Bucharest). 70:843–847. 2019.
|
